Sphingolipids - The enigmatic lipid class: Biochemistry, physiology, and pathophysiology

被引:561
作者
Merrill, AH
Schmelz, EM
Dillehay, DL
Spiegel, S
Shayman, JA
Schroeder, JJ
Riley, RT
Voss, KA
Wang, E
机构
[1] USDA ARS,TOXICOL & MYCOTOXIN RES UNIT,ATHENS,GA 30604
[2] EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322
[3] EMORY UNIV,SCH MED,DIV ANIM RESOURCES,ATLANTA,GA 30322
[4] GEORGETOWN UNIV,MED CTR,DEPT BIOCHEM & MOL BIOL,WASHINGTON,DC 20007
[5] UNIV MICHIGAN,DEPT INTERNAL MED,DIV NEPHROL,ANN ARBOR,MI 48109
[6] MICHIGAN STATE UNIV,DEPT FOOD SCI & HUMAN NUTR,E LANSING,MI 48824
关键词
D O I
10.1006/taap.1996.8029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ''sphingosin'' backbone of sphingolipids was so named by J. L. W. Thudichum in 1884 for its enigmatic (''Sphinx-like'') properties. Although still an elusive class of lipids, research on the involvement of sphingolipids in the signal transduction pathways that mediate cell growth, differentiation, multiple cell functions, and cell death has been rapidly expanding our understanding of these compounds. In addition to the newly discovered role of ceramide as an intracellular second messenger for tumor necrosis factor-alpha, IL-1 beta, and other cytokines, sphingosine, sphingosine-1-phosphate, and other sphingolipid metabolites have recently been demonstrated to modulate cellular calcium homeostasis and cell proliferation. Perturbation of sphingolipid metabolism using synthetic and naturally occurring inhibitors of key enzymes of the biosynthetic pathways is aiding the characterization of these processes; for examples, inhibition of cerebroside synthase has indicated a role for ceramide in cellular stress responses including heat shock, and inhibition of ceramide synthase (by fumonisins) has revealed the role of disruption of sphingolipid metabolism in several animal diseases. Fumonisins are currently the focus of a FDA long-term tumor study. This review summarizes recent research on (i) the role of sphingolipids as important components of the diet, (ii) the role of sphingoid base metabolites and the ceramide cycle in expression of genes regulating cell growth, differentiation, and apoptosis, (iii) the use of cerebroside synthase inhibitors as tools for understanding the role of sphingolipids as mediators of cell cycle progression, renal disease, and stress responses, and (iv) the involvement of disrupted sphingolipid metabolism in animal disease and cellular deregulation associated with exposure to inhibitors of ceramide synthase and serine palmitoyltransferase, key enzymes in de novo sphingolipid biosynthesis. These findings illustrate how an understanding of the function of sphingolipids can help solve questions in toxicology and this is undoubtedly only the beginning of this story. (C) 1997 Academic Press
引用
收藏
页码:208 / 225
页数:18
相关论文
共 170 条
[71]   INH, A NEGATIVE REGULATOR OF MPF, IS A FORM OF PROTEIN PHOSPHATASE-2A [J].
LEE, TH ;
SOLOMON, MJ ;
MUMBY, MC ;
KIRSCHNER, MW .
CELL, 1991, 64 (02) :415-423
[72]  
Lim Chae Woong, 1996, Natural Toxins, V4, P34, DOI 10.1002/19960401NT5
[73]  
LINARDIC CM, 1994, J BIOL CHEM, V269, P23530
[74]  
LOZANO J, 1994, J BIOL CHEM, V269, P19200
[75]   THE DISCOVERY OF AUSTRALIFUNGIN, A NOVEL INHIBITOR OF SPHINGANINE N-ACYLTRANSFERASE FROM SPORORMIELLA-AUSTRALIS - PRODUCING ORGANISM, FERMENTATION, ISOLATION, AND BIOLOGICAL-ACTIVITY [J].
MANDALA, SM ;
THORNTON, RA ;
FROMMER, BR ;
CUROTTO, JE ;
ROZDILSKY, W ;
KURTZ, MB ;
GIACOBBE, RA ;
BILLS, GF ;
CABELLO, MA ;
MARTIN, I ;
PELAEZ, F ;
HARRIS, GH .
JOURNAL OF ANTIBIOTICS, 1995, 48 (05) :349-356
[76]   INHIBITION OF SERINE PALMITOYL-TRANSFERASE ACTIVITY BY LIPOXAMYCIN [J].
MANDALA, SM ;
FROMMER, BR ;
THORNTON, RA ;
KURTZ, MB ;
YOUNG, NM ;
CABELLO, MA ;
GENILLOUD, O ;
LIESCH, JM ;
SMITH, JL ;
HORN, WS .
JOURNAL OF ANTIBIOTICS, 1994, 47 (03) :376-379
[77]   Molecular cloning and characterization of SCaMPER, a sphingolipid Ca2+ release-mediating protein from endoplasmic reticulum [J].
Mao, CG ;
Kim, SH ;
Almenoff, JS ;
Rudner, XL ;
Kearney, DM ;
Kindman, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :1993-1996
[78]   PRIMARY LIVER-CANCER AND ESOPHAGEAL BASAL-CELL HYPERPLASIA IN RATS CAUSED BY FUSARIUM-MONILIFORME [J].
MARASAS, WFO ;
KRIEK, NPJ ;
FINCHAM, JE ;
VANRENSBURG, SJ .
INTERNATIONAL JOURNAL OF CANCER, 1984, 34 (03) :383-387
[79]  
Marasas WFO, 1996, ADV EXP MED BIOL, V392, P1
[80]  
MARASAS WFO, 1988, ONDERSTEPOORT J VET, V55, P197